|
|
Article: Treatment of atopic dermatitis.(Focus)
- Article from:
- Chain Drug Review
- Article date:
- July 23, 2007
- Author:
CopyrightCOPYRIGHT 2007 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
This month's featured continuing education program focuses on addressing safety concerns in the treatment of atopic dermatitis (AD).
According to Dr. Jon Hanifin, professor of dermatology at Oregon Health and Science University, AD is a chronic, recurring inflammatory disease, characterized by skin barrier disruption, hyperactivity in response to irritants and allergens, and immune dysfunction. The hallmark symptoms of AD are dry skin and pruritus, which can be so severe that they cause intense, prolonged scratching, leading to a breakdown in skin barrier protection, excoriation and secondary infections, and disruption of sleep and social functioning that ...